Cargando…

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy

Highlights: ASS2324 is a hybrid compound resulting from the juxtaposition of donepezil and the propargylamine PF9601N. ASS2324 is a multi-target directed propargylamine able to bind to all the AChE/BuChE and MAO A/B enzymes. ASS2324 shows antioxidant, neuroprotective and suitable permeability proper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marco-Contelles, José, Unzeta, Mercedes, Bolea, Irene, Esteban, Gerard, Ramsay, Rona R., Romero, Alejandro, Martínez-Murillo, Ricard, Carreiras, M. Carmo, Ismaili, Lhassane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923252/ https://www.ncbi.nlm.nih.gov/pubmed/27445665 http://dx.doi.org/10.3389/fnins.2016.00294

Ejemplares similares

Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer’s disease therapy
por: Romero, Alejandro, et al.
Publicado: (2019)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism
por: Albreht, Alen, et al.
Publicado: (2018)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
por: Zribi, Lazhar, et al.
Publicado: (2020)

Solvent-free synthesis of propargylamines: an overview
por: Manujyothi, Ravi, et al.
Publicado: (2021)

Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
por: Bautista-Aguilera, Oscar M, et al.
Publicado: (2014)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Asymmetric synthesis of propargylamines as amino acid surrogates in peptidomimetics
por: Wünsch, Matthias, et al.
Publicado: (2017)

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy
por: Rodríguez-Ruiz, Emelina R., et al.
Publicado: (2023)

The Learned Ass
Publicado: (1896)

Efficient Gold(I) Acyclic Diaminocarbenes for the Synthesis of Propargylamines and Indolizines
por: Aliaga-Lavrijsen, Mélanie, et al.
Publicado: (2018)

N-Propargylamines: versatile building blocks in the construction of thiazole cores
por: Arshadi, S, et al.
Publicado: (2017)

Metal-free multicomponent approach for the synthesis of propargylamine: a review
por: Ghosh, Sujit, et al.
Publicado: (2021)

Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
por: Dakhlaoui, Imen, et al.
Publicado: (2023)

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
por: Choura, Emna, et al.
Publicado: (2022)

And Baalam’s Ass Spake
Publicado: (1901)

Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines
por: Mandler, Markus, et al.
Publicado: (2015)

The golden ass : being the metamorphoses of Lucius Apuleius
Publicado: (1915)

The golden ass : being the metamorphoses of Lucius Apuleius
por: Lucius Apuleius
Publicado: (1965)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2020)

Highly Selective Cyclization and Isomerization of Propargylamines to Access Functionalized Quinolines and 1-Azadienes
por: Wu, Zheng-Guang, et al.
Publicado: (2023)

SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer’s Disease
por: Unzeta, Mercedes, et al.
Publicado: (2021)

Each actor on his ass
por: Mac Liammóir, Micheál, 1899-1978
Publicado: (1961)

A Leadership Kick in the Ass
por: Treasurer, Bill
Publicado: (2017)

Feeding Infants with Asses’ Milk
Publicado: (1889)

Attempt to Infect the Ass with Tuberculin
Publicado: (1899)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
por: Dgachi, Youssef, et al.
Publicado: (2016)

Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives
por: Pachón Angona, Irene, et al.
Publicado: (2020)

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2016)

The Asymmetric A(3)(Aldehyde–Alkyne–Amine) Coupling: Highly Enantioselective Access to Propargylamines
por: Mo, Jia-Nan, et al.
Publicado: (2019)

Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
por: Pachòn Angona, Irene, et al.
Publicado: (2020)

23.4 Briefing
por: LeMaster, Joseph W
Publicado: (2020)

American Ass’n of Obstetricians and Gynecologists
Publicado: (1909)

Stone in the Bladder of a She-ass
por: Schimmel, W. C.
Publicado: (1896)

Transactions of the Amer. Med. Ass., for 1850
Publicado: (1851)

Transactions of Amer. Med. Ass’n.
Publicado: (1871)

Trans. Am. Med. Ass. 1856
Publicado: (1857)

Cannot write session to /tmp/vufind_sessions/sess_j3av2cjdp5io0cbtc42fb1qb72